BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026

Boston Scientific (BSX) Stock Hits New Low — Here’s What Wall Street Thinks

Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Boston Scientific (BSX) Stock Plunges to 52-Week Low: Analyst Downgrades Pile Up

Boston Scientific Trial Wins Highlight Growth Potential In Electrophysiology And Stroke Care

Massively Disappointing Boston Scientific (BSX) Stock Could Be Due for a Comeback

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A

Boston shares plethora of new findings on Farapulse PFA and Watchman LAAC devices

SAN DIEGO, CA / ACCESS Newswire / 28 de abril de 2026 / Robbins LLP recuerda a los accionistas que se presentó una demanda colectiva en nombre de todos los inversores que compraron o adquirieron acciones ordinarias de Boston Scientific Corporation (NYSE:BSX) entre el 23 de julio de 2025 y el 3 de febrero de 2026. Boston Scientific es una empresa global que desarrolla, fabrica y comercializa dispositivos médicos utilizados en diversas especialidades.

BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION

HRS 2026: Medtronic, Boston Scientific and Abbott debut key PFA data

Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm

UBS Adjusts Boston Scientific Price Target to $95 From $105, Maintains Buy Rating